These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 24946210)

  • 21. Inhibition of NF-κB signaling ablates the invasive phenotype of glioblastoma.
    Westhoff MA; Zhou S; Nonnenmacher L; Karpel-Massler G; Jennewein C; Schneider M; Halatsch ME; Carragher NO; Baumann B; Krause A; Simmet T; Bachem MG; Wirtz CR; Debatin KM
    Mol Cancer Res; 2013 Dec; 11(12):1611-23. PubMed ID: 24145173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of reactive oxygen species to migration/invasion of human glioblastoma cells U87 via ERK-dependent COX-2/PGE(2) activation.
    Chiu WT; Shen SC; Chow JM; Lin CW; Shia LT; Chen YC
    Neurobiol Dis; 2010 Jan; 37(1):118-29. PubMed ID: 19804834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.
    Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y
    Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin.
    Lamszus K; Brockmann MA; Eckerich C; Bohlen P; May C; Mangold U; Fillbrandt R; Westphal M
    Clin Cancer Res; 2005 Jul; 11(13):4934-40. PubMed ID: 16000592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isoflurane enhances the malignant potential of glioblastoma stem cells by promoting their viability, mobility in vitro and migratory capacity in vivo.
    Zhu M; Li M; Zhou Y; Dangelmajer S; Kahlert UD; Xie R; Xi Q; Shahveranov A; Ye D; Lei T
    Br J Anaesth; 2016 Jun; 116(6):870-7. PubMed ID: 27199319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy.
    Lucio-Eterovic AK; Piao Y; de Groot JF
    Clin Cancer Res; 2009 Jul; 15(14):4589-99. PubMed ID: 19567589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-218 reverses high invasiveness of glioblastoma cells by targeting the oncogenic transcription factor LEF1.
    Liu Y; Yan W; Zhang W; Chen L; You G; Bao Z; Wang Y; Wang H; Kang C; Jiang T
    Oncol Rep; 2012 Sep; 28(3):1013-21. PubMed ID: 22766851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-340-5p Suppresses Aggressiveness in Glioblastoma Multiforme by Targeting Bcl-w and Sox2.
    Kim S; Choi JY; Seok HJ; Park MJ; Chung HY; Bae IH
    Mol Ther Nucleic Acids; 2019 Sep; 17():245-255. PubMed ID: 31272074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apoptotic effect of atorvastatin in glioblastoma spheroids tumor cultured in fibrin gel.
    Bayat N; Ebrahimi-Barough S; Norouzi-Javidan A; Saberi H; Tajerian R; Ardakan MMM; Shirian S; Ai A; Ai J
    Biomed Pharmacother; 2016 Dec; 84():1959-1966. PubMed ID: 27836464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Whole transcriptome sequencing analyses of DHA treated glioblastoma cells.
    Ruan M; Liu J; Ren X; Li C; Zhao AZ; Li L; Yang H; Dai Y; Wang Y
    J Neurol Sci; 2019 Jan; 396():247-253. PubMed ID: 30529802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comprehensive view of tumor stem cells and their regulation by the microenvironment in glioblastoma.
    Schiffer D; Annovazzi L; Mellai M
    Neurol Sci; 2017 Mar; 38(3):527-529. PubMed ID: 27853910
    [No Abstract]   [Full Text] [Related]  

  • 32. [HDMF]Cl-based DES as highly efficient extractants and catalysts for oxidative desulfurization of model oil.
    Zhao RX; Li XP; Mao CF; Hou L; Gao X
    RSC Adv; 2019 May; 9(25):14400-14406. PubMed ID: 35519319
    [No Abstract]   [Full Text] [Related]  

  • 33. HDMF: Hierarchical Data Modeling Framework for Modern Science Data Standards.
    Tritt AJ; Rübel O; Dichter B; Ly R; Kang D; Chang EF; Frank LM; Bouchard K
    Proc IEEE Int Conf Big Data; 2019 Dec; 2019():165-179. PubMed ID: 34632466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and significance of SOX B1 genes in glioblastoma multiforme patients.
    Pan C; Liang L; Wang Z; Zhang B; Li Q; Tian Y; Yu Y; Chen Z; Wang X; Liu H
    J Cell Mol Med; 2022 Feb; 26(3):789-799. PubMed ID: 34953010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BCL-w: apoptotic and non-apoptotic role in health and disease.
    Hartman ML; Czyz M
    Cell Death Dis; 2020 Apr; 11(4):260. PubMed ID: 32317622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-29b attenuates tumorigenicity and stemness maintenance in human glioblastoma multiforme by directly targeting BCL2L2.
    Chung HJ; Choi YE; Kim ES; Han YH; Park MJ; Bae IH
    Oncotarget; 2015 Jul; 6(21):18429-44. PubMed ID: 26155940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3-Hydroxy-3',4'-dimethoxyflavone suppresses Bcl-w-induced invasive potentials and stemness in glioblastoma multiforme.
    Bae IH; Lee WS; Yun DH; Han YH; Lee JS
    Biochem Biophys Res Commun; 2014 Jul; 450(1):704-10. PubMed ID: 24946210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specificity protein 1 expression contributes to Bcl-w-induced aggressiveness in glioblastoma multiforme.
    Lee WS; Kwon J; Yun DH; Lee YN; Woo EY; Park MJ; Lee JS; Han YH; Bae IH
    Mol Cells; 2014 Jan; 37(1):17-23. PubMed ID: 24552705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined treatment with 2'-hydroxycinnamaldehyde and temozolomide suppresses glioblastoma tumorspheres by decreasing stemness and invasiveness.
    Jeong H; Park J; Shim JK; Lee JE; Kim NH; Kim HS; Chang JH; Yook JI; Kang SG
    J Neurooncol; 2019 May; 143(1):69-77. PubMed ID: 30887242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic anti-tumor actions of luteolin and silibinin prevented cell migration and invasion and induced apoptosis in glioblastoma SNB19 cells and glioblastoma stem cells.
    Chakrabarti M; Ray SK
    Brain Res; 2015 Dec; 1629():85-93. PubMed ID: 26471408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.